Mark Howarth, Professor of Protein Nanotechnology
Mark did graduate work in molecular immunology at Oxford University Institute of Molecular Medicine and Southampton
University Cancer Sciences. In his postdoctoral work at MIT he developed tools in chemical biology, advanced microscopy and
nanotechnology to understand receptor trafficking. He has been a PI at Oxford since 2007. In 2017 he was awarded the Royal
Society of Chemistry Norman Heatley Prize for chemical biology. He is a founder of SpyBiotech, which is now running clinical trials
for a Covid-19 vaccine, and Director of Entrepreneurship for the Biochemistry Department. His work has been funded by ERC,
BBSRC, EPSRC, MRC, Wellcome Trust and through collaborations with companies including AB Vista, QinetiQ, Sekisui Diagnostics
Sheryl Lim, DPhil student
Sheryl did her undergraduate training at Imperial College London. In Singapore she researched therapeutic targeting of tumour
suppressors and came to Oxford in 2018 on an A*STAR studentship. In the Howarth lab she has co-developed the NeissLock
system, towards long-lasting therapeutic delivery.
Anthony Keeble, PhD from UEA
Anthony is applying library selection and structure-based design to the engineering of fast-reacting and unbreakable protein
Arne Scheu, DPhil student
Arne did his MSc at KAUST and came to Oxford on a Rhodes Scholarship. He is harnessing bacterial protein reactivity towards a
new approach in therapeutic delivery.
Niels Wicke, DPhil student
Niels, originally from Germany, did his BSc at the University of Edinburgh and came to Oxford as part of the Interdisciplinary
Biosciences Doctoral Training Programme. He has an iCASE studentship with AB Vista and is establishing evolutionary platforms and
proteins allowing targeting in the gastrointestinal system. While in Oxford, he co-founded
and mentored Oxford’s iGEM team.
Claudia Driscoll, DPhil rotation student
Claudia did her undergraduate training at Durham University and joined Oxford’s Interdisciplinary Bioscience DTP. She is
developing new antibody architectures.
Hung-Jen Wu, DPhil student
Hung-Jen originally trained in Economics and Mathematics and then did an MSci on DNA methylation in cancer at Georgetown
University. He is enhancing the generation and design of nanoparticles to improve immune responses and vaccination.
Elizabeth Tasker, Part II student
Elizabeth is advancing NeissLock technology.
Dominic Wood, DPhil student
Dominic studied Biology at the University of York and took part in the iGEM competition in 2017. He is currently on the
Interdisciplinary Bioscience DTP.
Rory Hills, DPhil student
Rory studied at the University of Victoria, Canada where he established the University Synthetic Biology club and devised
analytical technology related to the opioid overdose crisis. He is a Rhodes Scholar, developing new vaccine technologies.
Susan did her doctoral work at King’s College London on innate immune sensing and autoimmune disease. She is currently
establishing protein switching technologies.
David Schramm, Part II student
David is studying how to improve vaccine potency by virus-like particle engineering.
Henry studied enzyme structural biology at the University of Sheffield and is developing protein nanoassembly approaches.
on joining this lab.
FIND FORMER MEMBERS
Robert Wieduwild, Group leader at
Rudolf-Schönheimer-Institut für Biochemie
, University of Leipzig, and founder of
Apurba Koner, Associate Prof. at
Indian Institute of Science Education and Research
Jayati Jain, co-founder with
Trutech Webs and the Fluid Motion
, Assistant Prof. at Mahidol University, Thailand
, Assistant Prof. at University of Nottingham
Anne-Marie Andersson, CTO at vaccine/immunotherapy spin-out
Theodora Bruun, Stanford Medical School
Denis Krndija, Group leader at
Centre de Biologie Intégrative (CBI), Toulouse
Rolle Rahikainen, University of Tampere
Irsyad Khairil Anuar, founder at
UKRI Future Leaders Fellow at Imperial College London
Jacob Fierer, Technology transfer
Gianluca Veggiani at
University of Toronto
Michael Fairhead at
Structural Genomics Consortium
, University of Oxford
Catharina Melzer at
Boston Consulting Group
Alberto Carella at
University of Manchester
Anselm Schneider at
Leibniz-Forschungsinstitut für Molekulare Pharmakologie
at Ludwig Maximilian University of Munich
Christopher Schoene at
Hoffmann Eitle Patent
Emily Chittock at Carpmaels & Ransford Intellectual Property
Linda Tchatchouang at GenScript
Sam Stokes at Intellectual Property Office
James Ross at University of Leeds
Karl Brune, founder at
Can Buldun at Roche
Anthony Walsh at
Raphael Gayet in
Jim Collins lab at MIT
Georgi Nikov at
Michael Jacobsen at
and Adjunct Assistant Professor, University of Utah
Anusuya Banerjee at
Department of Biochemistry,
University of Oxford,
South Parks Road,
t: 01865 613200
2021 Mark Howarth. All rights reserved.